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Introduction: It has been shown that progranulin (PGRN) deficiency causes age-related neurodegenerative diseases
such as frontotemporal lobar degeneration (FTLD) and neuronal ceroid lipofuscinosis (NCL), a lysosomal storage
disease. Previous studies also suggested that PGRN is involved in modulating lysosomal function. To elucidate the
pathophysiological role of PGRN in the aged brain, in the present study, lysosomal function and pathological
changes of the brain were investigated using 10- and 90-week-old wild-type and PGRN-deficient mice.
Results: We showed that PGRN deficiency caused enhanced CD68 expression in activated microglia and
astrogliosis in the cortex and thalamus, especially in the ventral posteromedial nucleus/ventral posterolateral
nucleus (VPM/VPL), in the aged brain. Immunoreactivity for Lamp1 (lysosome marker) in the VPM/VPL and
expression of lysosome-related genes, i.e. cathepsin D, V-type proton ATPase subunit d2, and transcription factor EB
genes, were also increased by PGRN deficiency. Aggregates of p62, which is selectively degraded by the
autophagy-lysosomal system, were observed in neuronal and glial cells in the VPM/VPL of aged PGRN-deficient
mice. TAR DNA binding protein 43 (TDP-43) aggregates in the cytoplasm of neurons were also observed in aged
PGRN-deficient mice. PGRN deficiency caused enhanced expression of glial cell-derived cytotoxic factors such as
macrophage expressed gene 1, cytochrome b-245 light chain, cytochrome b-245 heavy chain, complement C4,
tumor necrosis factor-α and lipocalin 2. In addition, neuronal loss and lipofuscinosis in the VPM/VPL and disrupted
myelination in the cerebral cortex were observed in aged PGRN-deficient mice.
Conclusions: The present study shows that aged PGRN-deficient mice present with NCL-like pathology as well as
TDP-43 aggregates in the VPM/VPL, where a particular vulnerability has been reported in NCL model mice. The
present results also suggest that these pathological changes in the VPM/VPL are likely a result of lysosomal dysfunction.
How PGRN prevents lysosomal dysfunction with aging remains to be elucidated.
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Progranulin (PGRN), which is a 68.5-kDa glycoprotein
containing 7.5 tandem repeats of a cysteine-rich motif, is
proteolytically processed into 6-kDa granulins (GRNs) [1].
PGRN is involved in multiple physiological functions and
various disease processes, including autoimmune disor-
ders, tumorigenesis, and insulin resistance [2-4]. In the
human brain, haploinsufficiency of PGRN is one of the
major factors causing frontotemporal lobar degeneration* Correspondence: amnishi@mail.ecc.u-tokyo.ac.jp
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available in this article, unless otherwise stated(FTLD) [5,6], which is characterized by ubiquitinated
cytoplasmic inclusions containing TAR DNA binding
protein 43 (TDP-43) [7]. However, the mechanism by
which impaired production of PGRN causes the forma-
tion of TDP-43 inclusions in the cytoplasm is not yet
fully understood.
We previously demonstrated that PGRN expression
increases after traumatic brain injury (TBI) in mice, and
the major source of PGRN is CD68-positive activated
microglia [8]. PGRN deficiency induces exacerbated in-
flammatory responses that are associated with increased
lysosomal biogenesis in activated microglia after TBI.
Further, the expression of cytotoxic factors is increasedLtd.; licensee BioMed Central Ltd. This is an Open Access article distributed
tribution License (http://creativecommons.org/licenses/by/4.0), which permits
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onal damage is exacerbated in PGRN-deficient mice [9].
Because microglial activation characterized by mor-
phologic and phenotypic changes also occurs with
aging [10], increased lysosomal biogenesis and cyto-
toxic factor production may occur with aging in acti-
vated microglia in PGRN-deficient mice. Wils et al.
suggested that PGRN-deficient mice have a disrupted
autophagy-lysosomal pathway with alterations in lyso-
somal homeostasis [11].
Patients with a homozygous mutation in the GRN gene
present with neuronal ceroid lipofuscinosis (NCL), a
group of neurodegenerative lysosomal storage disorders
[12]. Additionally, Götzl et al. (2014) recently revealed
that FTLD patients due to PGRN deficiency have NCL-
like pathology [13]. These reports suggest that disorders
with aging from PGRN deficiency occur associated with
lysosomal dysfunction. The NCLs display a relatively
uniform phenotype in the central nervous system that is
characterized by a dramatic loss of cortical neurons, pro-
nounced gliosis, and accumulation of lysosomal autofluo-
rescent lipopigments [14]. NCL model animals show a
particular vulnerability early during disease progression in
the sensory thalamocortical pathways, i.e., projections
from the ventral posteromedial nucleus/ventral postero-
lateral nucleus (VPM/VPL) of the thalamus to the pri-
mary somatosensory barrelfield cortex (S1BF) [15].
Localized aggregation of activated microglia and astro-
cytes followed by neuronal cell loss occur in this area
[16-18]. Impaired myelination also occurs as a feature of
some NCL models such as mice deficient in palmitoyl-
protein thioesterase 1 (Ppt1), ceroid-lipofuscinosis, neur-
onal 5 (Cln5), and ceroid-lipofuscinosis, neuronal 8 (Cln8)
genes [19,20]. However, characterization of the brain path-
ology regarding NCL in the VPM/VPL has yet to be per-
formed in PGRN-deficient mice.
In the present study, the effects of PGRN deficiency
on age-associated lysosomal biogenesis and function,
inflammatory responses, and TDP-43 aggregates in the
cytoplasm were investigated. Further, the brain pathology




In this study, 10- and 90-week-old female wild-type
(WT) and PGRN-deficient (KO) C57BL/6J mice were used.
They were produced from breeding heterozygous pairs in
our laboratory and were genotyped using previously de-
scribed protocols [21]. Mice were maintained under
controlled light (lights on, 07:00–19:00), temperature
(23 ± 1°C), and humidity (55 ± 10%), and were given free
access to food and water. All animal experiments were
performed in accordance with the Guide for the Careand Use of Laboratory Animals of the University of
Tokyo and were approved by the Institutional Animal
Care and Use Committee of the University of Tokyo
(Permit Number: P12-651).Antibodies
The primary antibodies from the following sources were
used for immunohistochemistry: mouse monoclonal
anti-ubiquitin antibody (MAB1510), rabbit polyclonal
anti-microtuble-associated protein 2 (MAP2) antibody
(AB5622), and rat monoclonal anti-CD11b antibody
(MAB1387Z) from Millipore (Billerica, MA, USA); rabbit
polyclonal anti-glial fibrillary acidic protein (GFAP) anti-
body (Z0334) and rabbit polyclonal anti-myelin basic
protein (MBP) antibody (A0623) from Dako (Glostrup,
Denmark); rabbit polyclonal anti-TDP-43 antibody (10782-
2-AP) from Proteintech (Chicago, IL, USA); rabbit
polyclonal anti-phospho-TDP-43 (Ser409/410) antibody
(TIP-PTD-P02) from CosmoBio (Tokyo, Japan); rabbit
polyclonal anti-ionized calcium-binding adapter-1 (Iba1)
antibody (019-19741) from Wako chemicals (Osaka, Japan);
rat monoclonal anti-CD68 antibody (MCA1957GA) from
AbD serotec (Oxford, UK); mouse monoclonal anti-MAP2
antibody (M1406) from Sigma (St. Louis, MO, USA);
guinea pig polyclonal anti-p62 antibody (03-GP62-C)
from American research products (Waltham, MA, USA);
rat monoclonal anti-lysosome associated membrane pro-
tein 1 (Lamp1) antibody (553792) from BD pharmingen
(Franklin Lakes, NJ, USA). Subsequently, the second-
ary antibodies from following sources were used:
biotin-conjugated goat anti-rabbit IgG antibody and
biotin-conjugated goat anti-guinea pig IgG from Vector
Laboratories (Burlingame, CA, USA); biotin-conjugated
donkey anti-rat IgG from Jackson ImmunoResearch La-
boratories (West Grove, PA, USA); Alexa Fluor 488 goat
anti-mouse IgG antibody, Alexa Fluor 594 goat anti-mouse
IgG antibody, Alexa Fluor 594 goat anti-rabbit IgG anti-
body, Alexa Fluor 594 goat anti-rat IgG antibody, and
Alexa Fluor 488 goat anti-guinea pig IgG antibody from
Invitrogen (Carlsbad, CA, USA).Traumatic brain injury (TBI)
TBI was placed in the cerebral cortex of 10- and 90-
week-old WT and KO mice as described previously [8].
Briefly, mice were anesthetized by intraperitoneal admin-
istration of xylazine hydrochloride (8 mg/kg) and chloral
hydrate (300 mg/kg) dissolved in sterile saline and sub-
sequently placed in a stereotaxic apparatus (Narishige,
Tokyo, Japan). The right cerebral cortex (1.3 mm lateral to
the midline, 1 to 3 mm posterior to the bregma, 2 mm in
depth) was exposed and injured with a stainless steel can-
nula with a 0.5-mm outer diameter. Brain samples were
taken 4 days after TBI under xylazine hydrochloride and
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Tissue preparation for histological analyses
For immunohistochemical studies, 10- and 90-week-old
WT and KO mice (n = 5 for each group) were used.
Mice were transcardially perfused with saline followed
by 4% paraformaldehyde in PBS (pH 7.2) under xylazine
hydrochloride and chloral hydrate anesthesia. Brains
were removed from the skull, postfixed in 4% paraformal-
dehyde overnight, immersed in 10% sucrose in PBS for 24
h, 20% sucrose for 24 h, and 30% sucrose for 48 h for cryo-
protection, and cut into 30-μm sections on a cryostat. Sec-
tions were preserved in PBS with 0.01% sodium azide.
Brain sections from bregma −1.46 to −1.82 were used for
the analysis. In the present study, we focused on age-
related phenotypical changes in the brain due to PGRN de-
ficiency, and analyzed the uninjured side of the brain unless
otherwise mentioned.
Immunochromogenic staining
Immunochromogenic staining for Iba1, CD68, Lamp1,
GFAP, p62, phospho-TDP-43 (pTDP-43) and MBP was
carried out on free-floating sections. In brief, sections
were incubated in 0.3% hydrogen peroxide for 30 min,
blocked in blocking solution (Block Ace, Snow Brand
Milk Products, Sapporo, Japan) at room temperature
(RT) for 2 h, and exposed to primary antibody (1:500) at
4°C for 60 h. Sections were incubated with biotinylated
secondary antibody (1:500) at RT for 2 h, amplified with
avidin-biotin complex (Vector Laboratories), and visualized
with 3-3′-diaminobenzidine (Sigma) as the chromogen for
1.5 min. All washes were done in 0.03% PBST, incubations
with primary and secondary antibodies were done in 0.3%
PBST containing 1% BSA, incubations with the avidin-
biotin complex were done in 0.3% PBST. Lamp1-, p62-,
and pTDP-43-stained sections were counterstained with
cresyl violet solution (0.2% cresyl violet, 0.1% acetic acid in
distilled water (DW)). Sections were mounted, dehydrated,
and coverslipped with Multi Mount 220 (Matsunami Glass,
Osaka, Japan). The sections were then observed under a
BX-53 microscope equipped with a DP-73 digital micro-
scope camera (Olympus, Tokyo, Japan).
To measure the immunoreactive (IR) areas, the number
of pixels per image with an intensity above the predeter-
mined threshold level was quantified, and the total was
calculated using NIH ImageJ software (National Institutes
of Health, Bethesda, MD, USA) as the percentage area
density, which is defined as the number of pixels divided
by the total number of pixels in the imaged field. To deter-
mine the number of Iba1-IR cells, cells with a clearly out-
lined, stained soma were counted. Images on the medial
and lateral region along the wound site (injured side) and
the comparable contralateral side (uninjured side) wereused for the analysis of the cerebral cortex. On the other
hand, four images of the left VPM/VPL without overlap-
ping were captured and used for the analysis of VPM/
VPL, and the values of the four images were averaged. For
analysis of the number of Iba1-IR cells in layers IV of the
S1BF, an image on the left S1BF was used. A rectangular
box (400 × 150 μm) was localized to layers IV of the S1BF,
and the number of Iba1-IR cells was counted. To measure
fractal dimension (FD) of Iba1-IR cells, ten images of
Iba1-IR cells of the left cerebral cortex and VPM/VPL
were used for analysis. FD was calculated by the software
(PopImaging v5.00, the trial version, http://www.dbkids.
co.jp), and the value of the ten images was averaged.
Immunofluorescent staining
Immunofluorescent staining for MAP2, GFAP, MBP,
CD68, p62, ubiquitin, and TDP-43 was carried out on
free-floating sections. To improve specific fluorescent sig-
nals and reduce autofluorescence, antigen retrieval and
Sudan black B treatment was performed as described previ-
ously [22]. Briefly, sections were incubated in 10 mM citrate
buffer (pH 6.0) at 90°C for 30 min, followed by incubation
in 0.1% Sudan black B (Wako Pure Chemicals) in 70% etha-
nol for 20 min at RT. The sections were blocked in block-
ing solution (Block Ace, Snow Brand Milk Products) at RT
for 2 h and exposed to primary antibody at 4°C for 60 h.
Sections were incubated with Alexa Fluor 488- or 594-
conjugated secondary antibody (1:500) at RT for 2 h.
Nuclei were stained with Hoechst33258 (0.1 μg/ml;
Polysciences Inc., Warrington, PA) at RT for 30 min. All
sections were mounted on glass slides and coverslipped
with fluoromount (Diagnostic BioSystems, Pleasanton,
CA). To analyze the localization of p62, the sections were
examined under an LSM 510 laser scanning confocal
microscope (Carl Zeiss, Oberkochen, Germany). For triple
staining for p62, ubiquitin, and Hoechst33258; p62, TDP-
43, and Hoechst33258, the sections were examined under
an LSM 5 PASCAL laser scanning confocal microscope
(Carl Zeiss).
Real-time PCR
The left thalamus was dissociated from 90-week-old WT
(n = 6) and KO mice (n = 5) using tweezers with a fine
tip. Total RNA was isolated from the samples with TRI-
zol (Invitrogen), and first-strand cDNA was synthesized
with SuperScriptII reverse transcriptase (Invitrogen).
PCR reactions for cathepsin D (Ctsd), V-type proton
ATPase subunit d 2 (Atp6v0d2), transcription factor EB
(Tfeb), macrophage expressed gene 1 (Mpeg1), cytochrome
b-245 light chain (Cyba), cytochrome b-245 heavy chain
(Cybb), complement C4 (C4), tumor necrosis factor α
(TNF-α), lipocalin 2 (Lcn2), p62, and hypoxanthine phos-
phoribosyltransferase (Hprt; an internal standard) were
performed with Thunderbird SYBR qPCR MIX (Toyobo,
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and each primer set listed in Additional file 1: Table S1.
The PCR reactions for Hprt were carried out as follows:
1 min at 95°C for the initial denaturation, followed by
40 cycles of amplification at 95°C for 15 s, 67°C for 20 s,
and 72°C for 15 s. For other primers, the PCR condi-
tions were: 1 min at 95°C for the initial denaturation,
followed by 40 cycles of amplification at 95°C for 15 s
and 60°C for 60 s. The genes of interest were normalized
to the expression level of Hprt.
Assessment of viable neurons
Viable neurons were visualized using Nissl staining.
For Nissl staining, the brain sections were mounted on
slides and dried at RT. The slides were incubated with
Nissl staining solution (0.2% cresyl violet, 0.1% acetic
acid in DW) for 30 min. The slides were washed with
DW, dehydrated, and coverslipped with Multi Mount
220 (Matsunami Glass). The sections were then ob-
served under a BX-53 microscope equipped with a
DP-73 digital microscope camera (Olympus). For ana-
lysis of the number of viable neurons in layers IV, V,
and VI of the S1BF, an image on the left S1BF was used.
A rectangular box (400 × 150 μm) was localized to
layers IV, V, and VI of the S1BF, and the number of vi-
able neurons was counted. For analysis in the VPM/
VPL, four images without overlapping were captured,
and the number of viable neurons was counted in each
image and averaged. A viable neuron was defined as a
neuron not exhibiting cytoplasmic shrinkage or nuclear
pyknosis.
Lipofuscin analysis
For autofluorescence analysis, brain sections were mounted
on slides, dried at RT, and coverslipped with fluoro-
mount (Diagnostic BioSystems). The sections were then
observed under a BX-53 microscope equipped with a
DP-73 digital microscope camera (Olympus). The CA3
area was isolated from the hippocampal image using
digital image manipulation software (GIMP v2.8.0, Open
source software, http://www.gimp.org/) and used for
analysis. Four images were captured to avoid overlap
with each other on the VPM/VPL. To measure the
autofluorescent areas, the number of pixels per image
with an intensity above the predetermined threshold
level was quantified, and the total was calculated using
NIH ImageJ software as the percentage area density,
which is defined as the number of pixels divided by the
total number of pixels in the imaged field. Further, the
brown-yellow pigment in the cytoplasm was evaluated
with hematoxylin staining, PAS reactivity after diastase
treatment, reducing substances by Schmorl staining,
and sudanophilia by Oil-red-O or Sudan black B
staining.Assessment of myelination
Myelination was visualized using avidin-biotin-peroxidase
complex method with diaminobenzidine as the chromo-
gen as described in the immunochromogenic staining.
The sections were observed under a BX-53 microscope
equipped with a DP-73 digital microscope camera
(Olympus). To analyze myelination in the temporal as-
sociation cortex (TeA) and ectorhinal cortex (Ect), an
image was captured on the left TeA and Ect, and the
image was binarized using digital image manipulation
software (GIMP v2.8.0). After that, the distance from
the terminal of MBP-IR area to the rim of the cortex in
the TeA and Ect was investigated using digital image
manipulation software (GIMP v2.8.0).
Statistical analyses
The data were analyzed with an unpaired t-test or two-
way ANOVA followed by a Tukey-Kramer test. Data are
expressed as the mean ± SEM. Differences were consid-
ered statistically significant when P < 0.05.
Results
PGRN deficiency leads to enhanced CD68 expression in
activated microglia
We first performed immunohistochemistry for Iba1, a
marker for microglia, and compared the morphology
and number of Iba1-IR cells between 10- and 90-week-
old WT and KO mice (Figure 1). Conspicuous accu-
mulation of Iba1-positive cells was observed in the
thalamus, especially in the VPM/VPL, on the uninjured
side of 90-week-old KO mice (Figure 1A). We therefore
focused on both the thalamus and the cerebral cortex
in this study. High-power images revealed that Iba1-IR
cells in 10-week-old mice were characterized by a small
soma and numerous thin, branched processes (ramified),
whereas those in 90-week-old mice had a larger soma
with fewer and shorter processes in both WT and KO
mice (Figure 1A), suggesting that microglia were acti-
vated with aging. Indeed, FD, which is the index for
the complexity of the morphology, of Iba1-IR cells in
WT and KO mice was decreased with aging both in the
cortex and VPM/VPL, while FD was not different between
90-week-old WT and KO mice both in the cortex and
VPM/VPL (Figure 1B and C). On the other hand, in the
cortex, the number of Iba1-IR cells was not different
among the groups (Figure 1D). In the VPM/VPL, the num-
ber of Iba1-IR cells was not different between 10-week-old
WT and KO mice, but significantly larger in KO mice than
WT mice at 90 weeks (Figure 1E).
Immunohistochemical images for CD68, a member of
the Lamp family expressed in microglia, in the cerebral
cortex and VPM/VPL are shown in Figure 2A. The
CD68-IR area was not significantly different between 10-
week-old WT and KO mice, but significantly larger in
Figure 1 Increased Iba1-IR cells in the VPM/VPL of aged PGRN-deficient mice. A, Iba1-immunostained images of the cerebral cortex (upper
images) and the VPM/VPL (lower images) of 10- and 90-week-old wild-type (WT) and PGRN-deficient (KO) mice. The magnified view is shown on
the lower-left corner of each image. Low-power field: scale bar = 200 μm. High-power field: scale bar = 25 μm. B, C, The fractal dimension (FD) of
Iba1-IR cells in the cerebral cortex (B) and VPM/VPL (C) of 10- and 90-week-old WT and KO mice. The figure in a box shows the magnified view
of the corresponding figure. The data are presented as the change relative to the number in 10-week-old WT mice. Values are the mean ± SEM
(n = 5 for each group). Values having a different superscript are significantly different (P < 0.05, Tukey-Kramer test). D, E, The number of Iba1-IR
cells in the cerebral cortex (D) and VPM/VPL (E) of 10- and 90-week-old WT and KO mice. The data are presented as the change relative to the
number in 10-week-old WT mice. Values are the mean ± SEM (n = 5 for each group). Values having a different superscript are significantly different
(P < 0.05, Tukey-Kramer test).
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and VPM/VPL (Figure 2C and D). Additionally, CD68-
IR cells in the VPM/VPL in PGRN-deficient mice were
round or amoeboid cells (Figure 2B). These results sug-
gest that PGRN deficiency enhances CD68 expression in
activated microglia in both the cerebral cortex and
VPM/VPL of the aged brain, although microgliosis with
aging was more prominent in the VPM/VPL.
PGRN deficiency leads to an increase in lysosomal
biogenesis
We then assessed lysosomal biogenesis using Lamp1
(lysosome marker) immunostaining in the layer V of
the cerebral cortex and the VPM/VPL of the thalamus
(Figure 3). The Lamp1-IR area was significantly in-
creased with aging in both the layer V and VPM/VPL.
Lamp1 immunoreactivity in the layer V was not different
between WT and KO mice at 10 weeks, but wassignificantly higher in KO mice than WT mice at 90
weeks of age (Figure 3A, B). Similarly, Lamp1 immunore-
activity in the VPM/VPL was not different between WT
and KO mice at 10 weeks, but was significantly higher in
KO mice than WT mice at 90 weeks of age (Figure 3A,
C). Further, we compared gene expressions of the lyso-
somal enzyme (Ctsd), protein (Atp6v0d2) and the master
regulator of lysosomal gene expression (Tfeb) in the thal-
amus between 90-week-old WT and KO mice. These gene
expressions in KO mice were significantly increased com-
pared to expression in WT mice (Figure 3D).
PGRN deficiency leads to an increase in astrogliosis
Next, we performed immunohistochemistry for GFAP, a
marker of astroglia (Figure 4). In both the cerebral cor-
tex and VPM/VPL, the GFAP-IR area was significantly
increased with aging. Although the GFAP-IR area was
not different between WT and KO mice at 10 weeks, the
Figure 2 Increased CD68 immunoreactivity in the cerebral cortex and VPM/VPL of aged PGRN-deficient mice. A, CD68-immunostained
images of the cerebral cortex (upper images) and VPM/VPL (lower images) of 10- and 90-week-old wild-type (WT) and PGRN-deficient (KO)
mice (scale bar = 200 μm). B, High-power image of CD68 immunostaining of the VPM/VPL of 90-week-old KO mice (scale bar = 10 μm).
C, D, CD68-positive area in the cerebral cortex (C) and VPM/VPL (D) of 10- and 90-week-old WT and KO mice. The data are presented as the
change relative to the level in 10-week-old WT mice. Values are the mean ± SEM (n = 5 for each group). Values having a different superscript are
significantly different (P < 0.05, Tukey-Kramer test).
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mice at 90 weeks of age in both areas (Figure 4A, C, and
D). As shown in Figure 4B, GFAP-IR astrocytes in the
VPM/VPL of 90-week-old WT mice showed variable de-
grees of cellular hypertrophy, suggesting mild to moderate
reactive astrogliosis. On the other hand, GFAP-IR astro-
cytes in 90-week-old KO mice had thicker processes, sug-
gesting severe diffuse reactive astrogliosis [23].
PGRN deficiency results in neuronal loss in the VPM/VPL
and increased microgliosis in the S1BF layer IV
We concentrated our analysis on the VPM/VPL and the
S1BF. Neurons in the VPM/VPL project to the S1BF,
and both of these structures show particular vulnerabi-
lity in previously reported NCL mouse models [15]. We
performed Nissl staining to compare the number of vi-
able neurons in the VPM/VPL in 10- and 90-week-old
WT and KO mice. The number of viable neurons was
not different among 10-week-old WT, 10-week-old KO,
and 90-week-old WT mice, but significantly decreased
in 90-week-old KO mice (Figure 5A and B). Next, weexamined gene expression of glial cell-derived cytotoxic
factors, i.e., Mpeg1, Cyba, Cybb, C4, TNF-α, and Lcn2 in
the left thalamus in 90-week-old mice. The expression of
all of these genes was significantly higher in KO mice
than in WT mice (Figure 5C). On the other hand, neu-
ronal loss was not detected in 90-week-old KO mice
in layers IV, V, and VI of the S1BF (data not shown).
However, the number of Iba1-positive cells in layer IV
of the S1BF, which receives projections from the VPM/
VPL, was significantly increased only in 90-week-old
KO mice (Figure 5D and E). These results suggest that
aged PGRN-deficient mice show particular vulnerability
in the VPM/VPL at least partially due to increased ex-
pression of cytotoxic factors by glial cells.
PGRN deficiency results in impaired cellular degradation
in lysosomes
To investigate cellular degradation in lysosomes, we per-
formed immunohistochemistry for p62, which is selectively
degraded by the autophagy-lysosomal pathway, in 10
and 90-week-old WT and KO mice. Considerable p62-
Figure 3 Increased lysosomal biogenesis in the cerebral cortex and VPM/VPL of aged PGRN-deficient mice. A, Lamp1-immunostained
images of the layer V of the cerebral cortex (upper images) and VPM/VPL (lower images) of 10- and 90-week-old wild-type (WT) and PGRN-deficient
(KO) mice (scale bar = 20 μm). B, C, Lamp1-positive area in the layer V of the cerebral cortex (B) and VPM/VPL (C) of 10- and 90-week-old WT and KO
mice. The data are presented as the change relative to the level in 10-week-old WT mice. Values are the mean ± SEM (n = 5 for each group). Values
having a different superscript are significantly different (P < 0.05, Tukey-Kramer test). D, Gene expressions of Ctsd, Atp6v0d2, and Tfeb in 90-week-old WT
and KO mice. The data are presented as the change relative to the level in WT mice. Values are the mean ± SEM (n = 6 for WT; n = 5 for KO, *P < 0.05,
unpaired t-test).
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only in 90-week-old KO mice (Figure 6A). The p62-IR
area in the VPM/VPL of 90-week-old mice was signifi-
cantly larger in KO mice than WT mice (Figure 6B),
although gene expression for p62 was not different
between 90-week-old WT and KO mice (Figure 6C).
Because a high-power image suggested that p62-positive
inclusions were present in both neuronal and glial cells
(Figure 6D), we next investigated what types of cells
in the VPM/VPL accumulated p62 using double im-
munostaining for p62 and MAP2 (neuronal marker),
GFAP (astrocyte marker), MBP (oligodendrocyte mar-
ker), and CD68 (microglia marker; mainly localized
to late endosomes and lysosomes). As shown in Figure 6E,
p62 was occasionally colocalized with MAP2, GFAP, MBP,
and CD68. In addition, some p62-positive inclusions
were also positive for ubiquitin (Figure 6F). These
results suggest that PGRN deficiency leads to disrup-
tion of the autophagy-lysosomal system in neuronal
and glial cells.PGRN deficiency leads to TDP-43 aggregation in the
cytoplasm of neurons and lipofuscin accumulation in
microglia
We next performed TDP-43 immunostaining in the
VPM/VPL in 10 and 90-week-old WT and KO mice.
TDP-43 immunoreactivity was decreased in 90-week-old
KO mice compared with other groups (Figure 7A), prob-
ably due to neuronal loss (see Figure 5A). Triple staining
for TDP-43, p62, and Hoechst33258 showed that the
TDP-43 aggregate colocalized with p62 in the cytoplasm
was observed only in aged KO mice (Figure 7B). Triple
staining for TDP-43, MAP2, and Hoechst33258 further
showed that the TDP-43 aggregate was present in the
cytoplasm of neurons in aged KO mice (Figure 7C).
Additionally, pTDP-43-IR aggregate was observed in
aged KO mice (Figure 7D).
To estimate lipofuscin accumulation, autofluorescence
in the cerebral cortex, hippocampus, and thalamus was
evaluated. Autofluorescence was not detected in 10-
week-old WT and KO mice (data not shown). On the
Figure 4 Increased GFAP immunoreactivity in the cerebral cortex and VPM/VPL of aged PGRN-deficient mice. A, GFAP-immunostained
images of the cerebral cortex (upper images) and VPM/VPL (lower images) of 10- and 90-week-old wild-type (WT) and PGRN-deficient (KO) mice
(scale bar = 200 μm). B, High-power GFAP-immunostained images of the VPM/VPL (scale bar: 20 μm) of 90-week-old WT and KO mice. C, D,
GFAP-positive area in the cerebral cortex (C) and VPM/VPL (D) of 10- and 90-week-old WT and KO mice. The data are presented as the change
relative to the level of 10-week-old WT mice. Values are the mean ± SEM (n = 5 for each group). Values having a different superscript are significantly
different (P < 0.05, Tukey-Kramer test).
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in the cerebral cortex and the CA3 of the hippocampus
between WT and KO mice, whereas it was significantly
increased in KO mice compared with WT mice in the
VPM/VPL (Figure 8A, B). Lipofuscin represents an
intracellular lipopigment of lysosomal origin and appears
in unstained sections as brown-yellow autofluorescent
intracellular granules that are positive for periodic acid-
Schiff (PAS), Schmorl, and Oil-red-O staining [24]. A
brown-yellow pigment was observed in the cytoplasm
(Figure 8C), and reactivity for Schmorl (Figure 8D), PAS
(Figure 8E), and Oil-red-O (Figure 8F) was positive in
the VPM/VPL in 90-week-old KO mice. Additionally,
double staining with Sudan black B and CD11b (micro-
glia marker; localized to the plasma membrane) revealed
that lipofuscin was accumulated in microglia in the
VPM/VPL of KO mice (Figure 8G).
PGRN deficiency results in impaired myelination in the
cerebral cortex
NCL mouse models such as Ppt1-, Cln5-, and Cln8-defi-
cient mice exhibit a loss of myelin as one of the typicaldisease features [19,20]. We therefore performed immu-
nohistochemical staining for MBP, a major protein con-
stituent of the myelin sheath that surrounds axons and
is synthesized by oligodendrocytes [25], using 10 and 90-
week-old WT and KO mice. Compared to 90-week-old
WT mice, MBP immunoreactivity in cerebral cortex, es-
pecially on the lateral side including the TeA and Ect,
was relatively disorganized in 90-week-old KO mice
(Figure 9A). The distance from the terminal of MBP-IR
area to the rim of the cortex in the TeA and Ect was
lessened with aging in WT mice, suggesting myelin was
formed with aging. On the other hand, in KO mice, the
distance was not different with aging, suggesting myelin
formation was disturbed (Figure 9B).
Discussion
The present study demonstrated that PGRN deficiency
leads to enhanced lysosomal biogenesis in the cerebral
cortex and thalamus, especially in the VPM/VPL, with
aging. Additionally, we showed impaired lysosomal func-
tion and the TDP-43 aggregate in the cytoplasm of neu-
rons in the VPM/VPL in aged PGRN-deficient mice.
Figure 5 Neuronal loss and increased expression of cytotoxic factors in the VPM/VPL of aged PGRN-deficient mice. A, Nissl-stained
images of the VPM/VPL of 10- and 90-week-old WT and KO mice (scale bar = 50 μm). B, The number of Nissl-positive cells in the VPM/VPL of
10- and 90-week-old WT and KO mice. The data are presented as the change relative to the number of 10-week-old WT mice. Values are presented as
the mean ± SEM (n = 5 for each group). Values having a different superscript are significantly different (P < 0.05, Tukey-Kramer test). C, Comparison of
gene expression for Mpeg1, C4, Cyba, Cybb, TNF-α, and Lcn2 between 90-week-old WT and KO mice in the thalamus. The data are presented as the
change relative to the level in WT mice. Values are the mean ± SEM (n = 6 for WT; n = 5 for KO, *P < 0.05, unpaired t-test). D, Iba1-immunostained
images in the layer IV of the S1BF of 10- and 90-week-old WT and KO mice (scale bar = 100 μm). E, The number of Iba1-IR cells in the VPM/VPL of
10- and 90-week-old WT and KO mice. The data are presented as the change relative to the number of 10-week-old WT mice. Values are presented as
the mean ± SEM (n = 5 for each group). Values having a different superscript are significantly different (P < 0.05, Tukey-Kramer test).
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like pathology. Thus, although the possibility that con-
tusion in the unilateral cerebral cortex might affect the
severity of histological changes and the levels of gene
expressions in the contralateral cortex and the thal-
amus could not be ruled out, substantial pathological
changes were observed in the aged brain due to PGRN
deficiency.In our previous study, we showed that although the
total number of Iba1-IR microglia was not different be-
tween WT and KO mice, CD68 immunoreactivity was
significantly higher in young (8- or 9-week-old) KO than
WT mice that underwent TBI [8]. In addition, we have
shown that PGRN deficiency leads to decreased mam-
malian target of rapamycin complex 1 (mTORC1) activ-
ity with a resultant increase in lysosomal biogenesis in
Figure 6 Excessive p62 accumulation in the VPM/VPL of PGRN-deficient mice with aging. A, p62-immunostained images with Nissl
counterstaining in the VPM/VPL of 10- and 90-week-old WT and KO mice (scale bar = 100 μm). B, C, p62-positive area (B) and p62 gene
expression (C) in the VPM/VPL of 90-week-old WT and KO mice. The data are presented as the change relative to the level of WT mice. Values
are the mean ± SEM (B: n = 5 for each group; C: n = 6 for WT, n = 5 for KO, *P < 0.05, unpaired t-test). D, High-power p62-immunostained image
with Nissl counterstaining (scale bar = 20 μm). E, Double-stained images of p62 (green) with MAP2 (red), GFAP (red), MBP (red), and CD68 (red)
in the VPM/VPL of 90-week-old KO mice (scale bar = 10 μm). F, The triple-stained image of p62 (green), ubiquitin (red) and Hoechst33258 (blue)
in the VPM/VPL of 90-week-old KO mice (scale bar = 10 μm).
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old) mice, the present study showed that both the
Lamp1 and CD68 immunoreactivity in the cerebral
cortex were significantly higher in KO than in WT
mice, even in the absence of TBI, whereas the number
of Iba1-IR microglia was not different between the twogenotypes. Thus, we made similar observations in the
TBI and aging models, both of which are associated
with microglial activation and microgliosis. PGRN
is therefore likely to be primarily implicated in lyso-





Figure 7 TDP-43 aggregation in the cytoplasm of neurons in the VPM/VPL of aged PGRN-deficient mice. A, TDP-43-immunostained
images in the VPM/VPL of 10- and 90-week-old WT and KO mice (scale bar = 500 μm). The area enclosed by dashed line indicates the VPM/VPL.
B, The triple-stained image of TDP-43 (red), p62 (green), and Hoechst33258 (blue) in the VPM/VPL of 90-week-old KO mice (scale bar = 50 μm).
C, The triple-stained image of TDP-43 (red), MAP2 (green), and Hoechst33258 (blue) in the VPM/VPL of 90-week-old KO mice (scale bar = 20 μm).
D, Phospho-TDP-43 (pTDP-43)-immunostained image with Nissl counterstaining in the VPM/VPL of 90-week-old KO mice (scale bar = 10 μm).
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deficient mice presented with increased accumulation
of p62 and ubiquitin in the VPM/VPL, where the main
pathological changes have been observed in reported
NCL model mice [15-18]. p62/ubiquitin inclusions have
been observed when the autophagy-lysosomal system is
disrupted [26]. Therefore, aged PGRN-deficient mice may
have an impaired autophagy-lysosomal system. Since p62inclusions were observed in neuronal and glial cells,
PGRN may play a role in maintaining lysosomal func-
tion during aging in both neuronal and glial cells. Disrup-
tion of both the ubiquitin-proteasome system and the
autophagy-lysosomal system is one of the characteristic fea-
tures of FTLD with TDP-43 inclusions in the cytoplasm of
neurons [27], and impaired production of PGRN is involved
in this pathology [5-7]. Previous studies reported increased
Figure 8 Increased lipofuscin accumulation in the VPM/VPL of aged PGRN-deficient mice. A, Autofluorescence images of the cerebral
cortex, hippocampus, and VPM/VPL of 90-week-old wild-type (WT) and PGRN-deficient (KO) mice (scale bar = 200 μm). B, Autofluorescence (AF)
area of the cerebral cortex, CA3 of the hippocampus, and VPM/VPL of 90-week-old WT and KO mice. Values are the mean ± SEM (n = 5 for each
group, *P < 0.05, unpaired t-test). C, D, E, F, Hematoxylin-stained (C), Schmorl-stained (D), periodic acid-Schiff (PAS)-stained (E), and Oil-red-O-stained
(F) images of the VPM/VPL of 90-week-old KO mice (scale bar = 20 μm). G, Images double-stained with Sudan black B and CD11b in the VPM/VPL of
90-week-old KO mice (scale bar = 10 μm). Black and white arrows indicate Sudan black B-positive and CD11b-positive cells, respectively.
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In the present study, TDP-43 colocalized with p62 in the
cytoplasm of neurons as well as the phosphorylated TDP-43
aggregate in the VPM/VPL were only observed in agedPGRN-deficient mice. Previous studies have shown that
abnormal degradation by the autophagy-lysosomal path-
way affects TDP-43 aggregation in the cytoplasm [29-32].
Taken together, these observations suggest that PGRN
Figure 9 Disrupted myelination in the cerebral cortex of aged
PGRN-deficient mice. A, Binary MBP-immunostained images in the
TeA and Ect of 10- and 90-week-old WT and KO mice (scale bar = 200
μm). Double dashed arrows indicate the distance from the terminal of
MBP-IR area to the rim of the cortex. B, The distance from the terminal
of MBP-IR area to the rim of the cortex in the TeA and Ect of 10- and
90-week-old WT and KO mice. The data are presented as the change
relative to the level in 10-week-old WT mice. Values are the mean ± SEM
(n = 5 for each group). Values having a different superscript are
significantly different (P < 0.05, Tukey-Kramer test).
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tion in the cytoplasm associated with impaired cellular
degradation by lysosomes.
We characterized the brain pathology related to NCL in
aged PGRN-deficient mice in the present study. PGRN
deficiency resulted in neuronal loss, increased gliosis,
lipofuscin accumulation in the VPM/VPL, and defective
myelination in the cerebral cortex. These pathological
changes in aged PGRN-deficient mice are partially con-
sistent with previous studies [11,13,33], though the
brain regions examined were different. Analyses using
NCL model mice in the previous studies revealed that
glial activation precedes neuronal loss in the VPM/VPL
[17,34]. Therefore, the particular vulnerability of the
VPM/VPL in PGRN-deficient mice might be attributed
to cytotoxicity of glial cells. Since expression of genes
for glial cell-derived neurotoxic factors was increasedin the VPM/VPL of aged PGRN-deficient mice, PGRN
deficiency is likely to make glial cells cytotoxic, thereby
leading to enhanced neuroinflammation with aging,
though further analysis on the vulnerability of the sen-
sory thalamocortical pathways in PGRN-deficient mice
might be needed. In addition, lipofuscin was accumu-
lated in microglia of aged PGRN-deficient mice. Lipo-
fuscin is thought to be an end product of cellular
protein metabolism, especially protein catabolism [24].
Since macrophage in PGRN-deficient mice displayed
enhanced rates of apoptotic-cell phagocytosis [35],
microglia in PGRN-deficient mice might be more pha-
gocytically active and thereby overloaded with waste
products with a resultant increase in lipofuscin de-
posits. In the present study, defective myelination and
enhanced astrogliosis occurred in the cerebral cortex of
aged PGRN-deficient mice, but neuronal loss was not
observed in the cerebral cortex. Similar observations
were also made in 3-month-old mice lacking Cln1, a
mutation in which causes classic infantile NCL [19].
Because astrocytes are implicated in myelination in the
brain [36,37], PGRN deficiency might lead to impaired
astrocyte function and consequently induce defective
myelination, though further studies are necessary to
elucidate myelination deficits due to PGRN deficiency.
These observations indicate that our PGRN-deficient
mice may be another useful experimental model for
NCL.
Recently, it is reported that PGRN-deficient mice re-
capitulate pathobiomedical features of NCL and FTLD,
e.g. increased lysosomal proteins and TDP-43 phos-
phorylation, and that FTLD patients due to PGRN
deficiency have NCL-like pathology [13]. The present
study also revealed that aged PGRN-deficient mice
have characteristic features for both FTLD and NCL.
Since lysosomal functions are involved in the patho-
genesis of these diseases [13,38,39], increased ly-
sosomal biogenesis and lysosomal dysfunction as
observed in PGRN-deficient mice in the present study
may be common processes in the pathogenic mechan-
ism of these diseases. We have previously suggested
that PGRN is localized in lysosomes and may be in-
volved in the activation of mTORC1, which prevents
translocation of TFEB to the nucleus by phosphoryl-
ation, thereby decreasing lysosomal biogenesis [9]. Fur-
ther studies on the molecular mechanism underlying
the actions of PGRN are needed to elucidate patho-
physiological changes of the aged brain due to PGRN
deficiency.
Conclusions
The present study demonstrated that aged PGRN-deficient
mice show exacerbated neuronal loss, lipofuscin accu-
mulation, gliosis, and increased lysosomal protein and
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http://www.actaneurocomms.org/content/2/1/78gene expressions in the VPM/VPL of the thalamus,
suggesting that aged PGRN-deficient mice develop NCL-
like pathology. In addition, the presence of p62 aggregates
in the VPM/VPL of aged PGRN-deficient mice suggests
that TDP-43 aggregates observed in the cytoplasm of neu-
rons in this brain region are associated with impaired
cellular degradation by lysosomal dysfunction. To our
knowledge, this is the first report showing NCL-like path-
ology and TDP-43 aggregates in the VPM/VPL of aged
PGRN-deficient mice. Clarifying the mechanisms by
which PGRN regulates lysosomal function may be crucial
to elucidate pathoetiology of brain disorders resulting from
PGRN deficiency.
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